Clinical Trial

Adaptive Deep Brain Stimulation (aDBS) Study (Early Adapter) Part II

Completed
View on ClinicalTrials.gov →
Summary
The purpose of the study is to evaluate the efficacy of aDBS (preferred mode, single or dual threshold) vs standard continuous DBS (cDBS) in decreasing Total Electrical Energy Delivered (TEED). Prospective randomized, single-blind, crossover, multicenter study of aDBS in subjects with Parkinson's disease.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-07-29; most recent amendment 2026-03-18.
Trial Details
NCT Number NCT07106242
Lead Sponsor MedtronicNeuro
Conditions Parkinson Disease
Enrollment 25 participants
Start Date 2021-11-29
Primary Completion 2023-05-08 (estimated)
Study Completion 2023-10-23 (estimated)
Updated on ClinicalTrials.gov 2026-03-19